|
The Central Drugs Standard Control Organisation (CDSCO) has announced a total of 168 drug samples tested across the country during the month of March, 2026, as Not of Standard Quality (NSQ).
Out of the total samples that failed the tests, 48 were identified in the Central Drugs Laboratories, while 120 were identified by the State Drugs Testing Laboratories.
"Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters. The failure is specific to the drug products of the batch tested by the Government Laboratory and it does not warrant any concerns on the other drug products available in the market," said the drug regulator.
During the month of March, 2026, one drug sample from Bihar is identified as spurious drugs, which was manufactured by unauthorized manufacturers using brand names owned by other companies. The drug regulator said that the matter is under investigation and action will be taken as per Act & Rules.
"This action of identifying NSQ and Spurious medicines is taken on regular basis in collaboration with state regulators to ensure that these drugs are identified and removed from the market," added the drug regulator.
It may be noted that the CDSCO has declared 194 samples as NSQs during the month of February, 2026, out of which 134 samples were reported by the State Laboratories. Four drug samples were declared as spurious during the month, on which investigations have been announced by the drug regulator.
|